NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ·Healthcare·Biotechnology
$2.96
-2.31%
Mkt Cap $52.38M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 23, 2026 | $7.53M | $983.00K | -86.94% | -$0.09 | $0.19 | +311.11% | — | — |
| Q4 2025 Nov 14, 2025 | $7.53M | $242.00K | -96.78% | -$0.11 | -$0.18 | -63.64% | — | — |
| Q2 2025 May 15, 2025 | — | $2.27M | — | -$0.30 | -$0.34 | -13.33% | — | — |
| Q1 2025 Mar 14, 2025 | $5.00M | $4.00K | -99.92% | -$0.20 | -$0.30 | -50.00% | — | — |
| Q4 2024 Nov 14, 2024 | — | — | — | -$0.81 | -$0.15 | +81.48% | — | — |
| Q3 2024 Aug 14, 2024 | — | — | — | -$0.81 | -$0.75 | +7.41% | — | — |
| Q2 2024 May 14, 2024 | — | — | — | -$0.55 | -$0.74 | -34.55% | — | — |
| Q1 2024 Mar 29, 2024 | — | $8.00K | — | -$0.70 | -$0.50 | +28.57% | — | — |
| Q4 2023 Nov 13, 2023 | — | — | — | -$1.10 | -$0.70 | +36.36% | — | — |
| Q3 2023 Aug 14, 2023 | — | — | — | -$1.40 | -$1.20 | +14.29% | — | — |
| Q2 2023 May 16, 2023 | — | — | — | -$1.50 | -$1.30 | +13.33% | — | — |
| Q1 2023 Mar 30, 2023 | — | — | — | -$1.40 | -$1.50 | -7.14% | — | — |
| Q4 2022 Nov 14, 2022 | — | — | — | -$1.40 | -$1.40 | +0.00% | — | — |
| Q3 2022 Aug 15, 2022 | — | — | — | -$1.00 | -$1.50 | -50.00% | — | — |
| Q2 2022 May 16, 2022 | — | — | — | — | -$2.50 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$0.90 | — | — | — |
| Q4 2021 Nov 16, 2021 | — | — | — | — | -$3.90 | — | — | — |
| Q3 2021 Aug 16, 2021 | — | — | — | — | -$65.10 | — | — | — |
| Q2 2021 May 20, 2021 | — | — | — | — | -$0.71 | — | — | — |
| Q2 2021 Apr 1, 2021 | — | — | — | — | -$16.73 | — | — | — |